Wells Fargo’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-62
| Closed | -$32 | – | 7857 |
|
|
2023
Q3 | $32 | Buy |
62
+31
| +100% | +$22 | ﹤0.01% | 7049 |
|
|
2023
Q2 | $22 | Buy |
31
+1
| +3% | +$1 | ﹤0.01% | 7287 |
|
|
2023
Q1 | $37 | Sell |
30
-32
| -52% | -$34 | ﹤0.01% | 7194 |
|
|
2022
Q4 | $51 | Buy |
62
+45
| +265% | +$50 | ﹤0.01% | 7000 |
|
|
2022
Q3 | $0 | Buy |
17
+2
| +13% | +$5 | ﹤0.01% | 7939 |
|
|
2022
Q2 | $0 | Buy |
15
+1
| +7% | +$4 | ﹤0.01% | 7987 |
|
|
2022
Q1 | $0 | Buy |
14
+3
| +27% | +$15 | ﹤0.01% | 8299 |
|
|
2021
Q4 | $0 | Sell |
11
-5
| -31% | -$57 | ﹤0.01% | 8207 |
|
|
2021
Q3 | $0 | Buy |
16
+2
| +14% | +$34 | ﹤0.01% | 7849 |
|
|
2021
Q2 | $0 | Buy |
14
+2
| +17% | +$41 | ﹤0.01% | 7791 |
|
|
2021
Q1 | $0 | Buy |
12
+4
| +50% | +$100 | ﹤0.01% | 7679 |
|
|
2020
Q4 | $0 | Buy |
8
+1
| +14% | +$31 | ﹤0.01% | 7316 |
|
|
2020
Q3 | $0 | Buy |
7
+6
| +600% | +$289 | ﹤0.01% | 7203 |
|
|
2020
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 7093 |
|
|
2020
Q1 | $0 | Buy |
+1
| New | +$78 | ﹤0.01% | 7100 |
|
|
2019
Q4 | – | Sell |
-25
| Closed | -$2K | – | 6900 |
|
|
2019
Q3 | $2K | Sell |
25
-176
| -88% | -$11.5K | ﹤0.01% | 6231 |
|
|
2019
Q2 | $10K | Sell |
201
-208
| -51% | -$36.1K | ﹤0.01% | 5923 |
|
|
2019
Q1 | $88K | Buy |
409
+264
| +182% | +$106K | ﹤0.01% | 5176 |
|
|
2018
Q4 | $50K | Buy |
145
+14
| +11% | +$10.9K | ﹤0.01% | 5519 |
|
|
2018
Q3 | $151K | Sell |
131
-6
| -4% | -$5.53K | ﹤0.01% | 5162 |
|
|
2018
Q2 | $117K | Sell |
137
-141
| -51% | -$117K | ﹤0.01% | 5312 |
|
|
2018
Q1 | $326K | Buy |
278
+108
| +64% | +$119K | ﹤0.01% | 4692 |
|
|
2017
Q4 | $157K | Buy |
170
+74
| +77% | +$68.3K | ﹤0.01% | 5087 |
|
|
2017
Q3 | $105K | Buy |
96
+93
| +3,100% | +$106K | ﹤0.01% | 5215 |
|
|
2017
Q2 | $3K | Sell |
3
-18
| -86% | -$21.9K | ﹤0.01% | 6018 |
|
|
2017
Q1 | $24K | Sell |
21
-3
| -13% | -$2.9K | ﹤0.01% | 5668 |
|
|
2016
Q4 | $25K | Buy |
24
+23
| +2,300% | +$10.4K | ﹤0.01% | 5578 |
|
|
2016
Q3 | $0 | Sell |
1
-6
| -86% | -$2.45K | ﹤0.01% | 6420 |
|
|
2016
Q2 | $3K | Hold |
7
| – | – | ﹤0.01% | 5910 |
|
|
2016
Q1 | $3K | Buy |
7
+6
| +600% | +$2.32K | ﹤0.01% | 5982 |
|
|
2015
Q4 | $1K | Sell |
1
-2
| -67% | -$1.4K | ﹤0.01% | 6131 |
|
|
2015
Q3 | $3K | Buy |
+3
| New | +$2.73K | ﹤0.01% | 5946 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6351 |
|
|
2014
Q1 | – | Sell |
-7
| Closed | -$14.6K | – | 6151 |
|
|
2013
Q4 | $8K | Sell |
7
-5
| -42% | -$7.99K | ﹤0.01% | 5250 |
|
|
2013
Q3 | $23K | Buy |
+12
| New | +$22.3K | ﹤0.01% | 4921 |
|
Other funds holding HSTO
Wells Fargo's HSTO Position: Q4 2023 in Review
Wells Fargo sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 62 shares — an estimated $32 sold.
Wells Fargo first reported a position in HSTO in Q3 2013 and held it in 34 quarters. The position peaked at $326K in Q1 2018. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.
- Wells Fargo reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Wells Fargo sold 62 Histogen Inc. Common Stock shares in Q4 2023, an estimated $32.
- Wells Fargo first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 34 quarters.
- Wells Fargo's Histogen Inc. Common Stock position peaked at $326K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.
Based on Wells Fargo's 13F filing for Q4 2023, filed 9 Feb 2024.